BREWSTER et al. - Google Patents
The Potential Use ol Gyclodextrins in Parenteral FormulationsBREWSTER et al.
View PDF- Document ID
- 9238175126998458241
- Author
- BREWSTER M
- SIMPKNSti W
- STERN C
External Links
Snippet
The general use of cyclodextrins in drugformulations is reuiewed. The ability of cyclodextrins to form reuersible inclusion complexes with many drugs can eliminate uarious undesirable physicochemical properties. While B-cyclodextrin is extremely useful in many of these …
- 239000000203 mixture 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
- A61K47/48969—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene inclusion being performed with a cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4439596B2 (en) | Pharmaceutical composition containing polar drug or polar prodrug having long shelf life, and method for producing the same | |
| DE69331900T2 (en) | CYCLODEXTRIN DERIVATIVES WITH INCREASED WATER SOLUBILITY AND THEIR USE | |
| Albers et al. | Cyclodextrin derivatives in pharmaceutics | |
| Szejtli | Past, present and futute of cyclodextrin research | |
| DE69130165T2 (en) | CYCLODEXTRIN DERIVATIVES WITH INCREASED WATER-SOLUBILITY AND THEIR USE | |
| US4727064A (en) | Pharmaceutical preparations containing cyclodextrin derivatives | |
| Bekers et al. | Cyclodextrins in the pharmaceutical field | |
| Miranda et al. | Cyclodextrins and ternary complexes: technology to improve solubility of poorly soluble drugs | |
| EP0437478B1 (en) | Cyclodextrin-peptide complexes | |
| DE69433052T2 (en) | Pharmaceutical compositions containing diclofenac and 2-hydroxypropyl-beta-cyclodextrin | |
| DE69221252T2 (en) | Lipophilic compositions of oligosaccharide antibiotic salts | |
| WO1994002518A9 (en) | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof | |
| US6077871A (en) | Droloxifene pharmaceutical compositions | |
| WO1996032135A1 (en) | Pharmaceutical composition | |
| Brewster et al. | Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-β-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse | |
| EP0399716B1 (en) | Hypoallergenic steroidal anesthetic/hypnotic compositions | |
| Rajewski | Development and evaluation of the usefulness and parenteral safety of modified cyclodextrins | |
| BREWSTER et al. | The Potential Use ol Gyclodextrins in Parenteral Formulations | |
| Devi et al. | Cyclodextrins in pharmacy-an overview | |
| WO1996041646A2 (en) | Pharmaceutical compositions containing lornoxicam and cyclodextrin | |
| Frijlink | Biopharmaceutical aspects of cyclodextrins | |
| JP2805539B2 (en) | Poly-γ-cyclodextrin inclusion compound | |
| Panda et al. | Cyclodextrin as carrier for drug delivery systems | |
| WO2024246793A1 (en) | Active ingredient complex and method of making thereof | |
| KUM et al. | THE CYCLODEXTRINS: A REVIEW |